Cargando…

Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database

BACKGROUND: Helicobacter pylori (H. pylori) infection is a risk factor for many diseases, including peptic ulcer disease and gastric cancer. While H. pylori eradication therapy can prevent these diseases, potentially unfavorable effects of eradication therapy have also been reported in some diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizukami, Kazuhiro, Sugano, Kentaro, Takeshima, Tomomi, Murakami, Kazunari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896615/ https://www.ncbi.nlm.nih.gov/pubmed/36742170 http://dx.doi.org/10.3748/wjg.v29.i4.692

Ejemplares similares

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
por: Yamada, Shinya, et al.
Publicado: (2016)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Current status of Helicobacter pylori eradication and risk factors for eradication failure
por: Yan, Tian-Lian, et al.
Publicado: (2020)

Helicobacter pylori infection in subjects negative for high titer serum antibody
por: Toyoshima, Osamu, et al.
Publicado: (2018)

Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients
por: Fu, Ying-Li, et al.
Publicado: (2022)

Analysis of long-term serological and histological changes after eradication of Helicobacter pylori
por: Fukuda, Kensuke, et al.
Publicado: (2022)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis
por: Benson III, Al B, et al.
Publicado: (2017)

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)

Mucosal patterns change after Helicobacter pylori eradication: Evaluation using blue laser imaging in patients with atrophic gastritis
por: Nishikawa, Yoshiyuki, et al.
Publicado: (2023)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Hepatitis C eradication with sofosbuvir leads to significant metabolic changes
por: Morales, Amilcar L, et al.
Publicado: (2016)

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018)

Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication
por: Sakitani, Kosuke, et al.
Publicado: (2020)

Two-day enema antibiotic therapy for parasite eradication and resolution of symptoms
por: Roshan, Niloufar, et al.
Publicado: (2020)

Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes
por: Okimoto, Tadayoshi, et al.
Publicado: (2016)

Differences in Helicobacter pylori and CagA antibody changes after eradication between subjects developing and not developing gastric cancer
por: Kodama, Masaaki, et al.
Publicado: (2019)

Differences in Regression Patterns of Complete and Incomplete Intestinal Metaplasia at Ten Years after Helicobacter pylori Eradication
por: Wada, Yasuhiro, et al.
Publicado: (2021)

Differences in clinical features and morphology between differentiated and undifferentiated gastric cancer after Helicobacter pylori eradication
por: Kodama, Masaaki, et al.
Publicado: (2023)

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
por: Lu, Ming-Ying, et al.
Publicado: (2022)

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
por: Tokunaga, Kengo, et al.
Publicado: (2021)

Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success
por: Kim, Beom Jin, et al.
Publicado: (2019)

Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia
por: Kodama, Masaaki, et al.
Publicado: (2015)

Is a split-dose regimen of 2 L polyethylene glycol plus ascorbic acid tolerable for colonoscopy in an early morning visit to a comprehensive medical check-up?
por: Seo, Ji Yeon, et al.
Publicado: (2017)

Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
por: Nishida, Shinya, et al.
Publicado: (2019)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Assessment of the July effect in post-endoscopic retrograde cholangiopancreatography pancreatitis: Nationwide Inpatient Sample
por: Schulman, Allison R, et al.
Publicado: (2017)

Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study
por: Moon, Jung Min, et al.
Publicado: (2020)

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
por: Kim, Beom Jin, et al.
Publicado: (2016)

Risk factors and prediction score for chronic pancreatitis: A nationwide population-based cohort study
por: Lin, Yen-Chih, et al.
Publicado: (2018)

Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study()
por: Azadbakht, Saleh, et al.
Publicado: (2022)

Relationships of hospitalization outcomes and timing to endoscopy in non-variceal upper gastrointestinal bleeding: A nationwide analysis
por: Weissman, Simcha, et al.
Publicado: (2023)

Effectiveness of treating menorrhagia using microwave endometrial ablation at a frequency of 2.45 GHz
por: Kakinuma, Toshiyuki, et al.
Publicado: (2023)

Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017)
por: Alukal, Joseph J, et al.
Publicado: (2021)

Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
por: Park, Seona, et al.
Publicado: (2018)

Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan
por: Tseng, Guan-Woei, et al.
Publicado: (2021)

Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1
por: Ozono, Yoshinori, et al.
Publicado: (2017)

Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
por: Choi, Catherine J, et al.
Publicado: (2020)

LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study
por: Lai, Hsiang-Chun, et al.
Publicado: (2023)

Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology
por: Uehara, Daisuke, et al.
Publicado: (2018)

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
por: Zhang, Yu-Feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8fea89iasltq9n9nhv8gtdrp6p